YM155 reverses rapamycin resistance in renal cancer by decreasing survivin.
Koike H, Nitta T, Sekine Y, Arai S, Furuya Y, Nomura M, Matsui H, Shibata Y, Ito K, Oyama T, Suzuki K.
Koike H, et al. Among authors: arai s.
J Cancer Res Clin Oncol. 2014 Oct;140(10):1705-13. doi: 10.1007/s00432-014-1734-z. Epub 2014 Jun 11.
J Cancer Res Clin Oncol. 2014.
PMID: 24916171